Type II Diabetes in Young Pregnant and Non-Pregnant Women

1. Clinical Context Before Notelovitz’s Work

Before the 1970s–1980s:

Type II diabetes was viewed almost exclusively as a disease of older adults

Young women with hyperglycemia were often:

Misclassified as Type I diabetics

Or labeled as having only gestational diabetes

The metabolic risks of young, non-pregnant, insulin-resistant women were poorlyrecognized

Pregnancy outcomes in young women with early Type II diabetic physiology wereoften poorly predicted and poorly managed

2. Notelovitz’s Key Contributions

A. Recognition of Type II Diabetes in Young Women

Notelovitz helped establish that:

Type II diabetes can occur in adolescents and young adults, including:

Non-obese women

Women with subtle insulin resistance

Many women previously labeled as “gestational diabetics” actually had:

Underlying early Type II diabetes

Or pre-diabetic metabolic syndrome

This shifted clinical thinking away from age-restricted models of diabetes.

B. Differentiation Between:

True Gestational Diabetes (GDM)vs

Pre-existing Type II Diabetes unmasked by pregnancy

Notelovitz emphasized that:

Pregnancy acts as a physiologic “stress test” for insulin resistance

Women who fail this test early or severely often have:

Undiagnosed Type II diabetes

Or significant pre-diabetic insulin resistance

This distinction was critical because:

C. Focus on Young Pregnant Women With Type II Physiology

His work showed that young pregnant women with Type II diabetes had:

Higher rates of:

Macrosomia

Preeclampsia

Shoulder dystocia

Neonatal hypoglycemia

Worse outcomes when:

Mismanaged as Type I

Or undertreated as “mild GDM”

He promoted:

Aggressive metabolic control

Early insulin therapy when oral control failed

Close fetal growth surveillance

D. Young Non-Pregnant Women With Early Type II Diabetes

Notelovitz highlighted that young non-pregnant Type II diabetics frequently had:

Polycystic ovary syndrome–like physiology

Hyperinsulinemia even before hyperglycemia

Increased risk for:

Infertility

Early cardiovascular disease

Later pregnancy complications

This helped link:

Reproductive endocrinology + early metabolic disease

Decades before the concept of reproductive-metabolic syndrome became widespread.

3. Impact on Modern Clinical Practice

Notelovitz’s work contributed to: 

Routine postpartum glucose testing after GDM 

Recognition that:

Many “gestational diabetics” are actually early Type II diabetics 

Earlier lifestyle and pharmacologic intervention in young women 

Integration of:

Obstetrics

Endocrinology

Preventive cardiometabolic medicine

2. 3. 4. 

These concepts are now embedded in:

ACOG

ADA

Endocrine Society guidelines

4. Conceptual Advances Linked to His Work

Notelovitz helped advance the idea that:

Type II diabetes begins decades before diagnosis

Pregnancy is:

A metabolic unmasking event

Young women with glucose intolerance are a high-risk cardiometabolic population,not a temporary obstetric issue

5. Historical Significance

His contributions were particularly important because they:

Bridged:

Obstetrics

Reproductive endocrinology

Preventive diabetology

Shifted diabetes thinking from:

“An older person’s disease” to “A life-course metabolic disorder beginning in youth”

Resources